Targeted formulations of GLP -1 for Type 1 diabetes

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$1,000,600.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43DK069727-01
Agency Tracking Number:
DK069727
Solicitation Year:
2004
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Small Business Information
PHARMAIN
PHARMAIN, 650 BUCKTHORN TERR, BUFFALO GROVE, IL, 60089
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 ELIJAH Bolotin
 (847) 947-0900
 ebolotin@pharmain.com
Business Contact
Phone: (847) 947-0900
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): New therapies are desperately needed for patients with Type 1 diabetes. Recent reports that the insulin-stimulating hormone Glucagon-Like Peptide (GLP-1), can increase pancreatic beta cell mass, offers the exciting

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government